...
首页> 外文期刊>Expert opinion on drug delivery >Evaluation of a new durable insulin pen with memory function among people with diabetes and healthcare professionals
【24h】

Evaluation of a new durable insulin pen with memory function among people with diabetes and healthcare professionals

机译:在糖尿病患者和医疗保健专业人员中评估一种具有记忆功能的新型耐用胰岛素笔

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objectives: The aim of the study was to evaluate durable insulin pens among people with diabetes (PwD) and healthcare professionals (HCPs), by comparing two durable insulin pens with memory function: NovoPen? 5 (NP5) and HumaPen? Memoir ? (HPM), and two durable insulin pens without memory function: HumaPen Luxura? (HPL) and ClikSTAR? (CS). Research design and methods: This cross-over, multicentre usability test was conducted in China, Germany and the UK. Participants evaluated all four pens in randomised order by performing handling and usability tasks related to everyday use during a face-to-face interview. Tasks, pens and preferences were rated by completing a questionnaire comprising of rating and open-ended questions. Results: NP5 was preferred by 51% of participants compared with HPM (22%, p 0.01), HPL (12%, p 0.01) and CS (15%, p 0.01). Participants preferred the design of NP5 (in particular, appearance, length and robustness). Memory function for the two pens was rated equally by participants, but 54% of PwD rated NP5 as 'very easy' to learn to use versus 22% for HPM and significantly more HCPs found it 'very easy' to teach patients to use NP5 versus HPM (6-point rating scale; difference in mean score, p 0.01). Substantially, more PwD would be confident in using NP5 (64%) compared with HPM (43%), HPL (49%) and CS (45%) (6-point rating scale; difference in mean score, p 0.01). Conclusions: NP5 was preferred by 50% of PwD and HCPs. NP5 was more highly rated for design, memory function and ease of learning/teaching compared with HPM. Most PwD would be confident in using NP5 for administering daily insulin injections.
机译:目的:通过比较两种具有记忆功能的耐久胰岛素笔:NovoPen,该研究的目的是评估糖尿病患者(PwD)和医护专业人员(HCP)的耐久胰岛素笔。 5(NP5)和HumaPen?回忆录? (HPM),以及两种不带记忆功能的耐用胰岛素笔:HumaPen Luxura? (HPL)和ClikSTAR? (CS)。研究设计和方法:这项跨多中心可用性测试是在中国,德国和英国进行的。参加者在面对面访问期间通过执行与日常使用相关的处理和可用性任务,以随机顺序对所有四支笔进行了评估。通过填写包括评分和不限成员名额问题的问卷,对任务,笔和偏好进行了评分。结果:与HPM(22%,p <0.01),HPL(12%,p <0.01)和CS(15%,p <0.01)相比,有51%的参与者更喜欢NP5。参与者更喜欢NP5的设计(特别是外观,长度和坚固性)。参与者对两支笔的记忆功能给予了相同的评价,但PwD的54%的人将NP5评定为“非常容易”学习,而HPM的评定为22%,并且明显更多的HCP认为教患者使用NP5相对而言“非常容易” HPM(6分等级量表;平均分差异,p <0.01)。基本上,与使用HPM(43%),HPL(49%)和CS(45%)相比,使用NP5(64%)的PwD更有信心(6分制评分;平均得分差异,p <0.01)。结论:> 50%的PwD和HCP首选NP5。与HPM相比,NP5在设计,存储功能和易于学习/教学方面获得更高的评价。大多数PwD有信心使用NP5进行每日胰岛素注射。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号